Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 174

1.

Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers.

Tsuneizumi M, Emi M, Nagai H, Harada H, Sakamoto G, Kasumi F, Inoue S, Kazui T, Nakamura Y.

Clin Cancer Res. 2001 Nov;7(11):3526-32.

PMID:
11705872
[PubMed - indexed for MEDLINE]
Free Article
2.

A highly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer.

Tsuneizumi M, Nagai H, Harada H, Kazui T, Emi M.

Ann Hum Biol. 2002 Jul-Aug;29(4):457-60.

PMID:
12160478
[PubMed - indexed for MEDLINE]
3.

Promoter analysis and chromosomal mapping of human EBAG9 gene.

Ikeda K, Sato M, Tsutsumi O, Tsuchiya F, Tsuneizumi M, Emi M, Imoto I, Inazawa J, Muramatsu M, Inoue S.

Biochem Biophys Res Commun. 2000 Jul 5;273(2):654-60.

PMID:
10873660
[PubMed - indexed for MEDLINE]
4.

Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen.

Tsuchiya F, Ikeda K, Tsutsumi O, Hiroi H, Momoeda M, Taketani Y, Muramatsu M, Inoue S.

Biochem Biophys Res Commun. 2001 Jun 1;284(1):2-10.

PMID:
11374862
[PubMed - indexed for MEDLINE]
5.

Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors.

Scorilas A, Chiang PM, Katsaros D, Yousef GM, Diamandis EP.

Gene. 2003 May 22;310:79-89.

PMID:
12801635
[PubMed - indexed for MEDLINE]
6.

EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.

Suzuki T, Inoue S, Kawabata W, Akahira J, Moriya T, Tsuchiya F, Ogawa S, Muramatsu M, Sasano H.

Br J Cancer. 2001 Nov 30;85(11):1731-7.

PMID:
11742495
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer.

Takahashi S, Urano T, Tsuchiya F, Fujimura T, Kitamura T, Ouchi Y, Muramatsu M, Inoue S.

Int J Cancer. 2003 Sep 1;106(3):310-5.

PMID:
12845666
[PubMed - indexed for MEDLINE]
8.

Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer.

Reiter RE, Sato I, Thomas G, Qian J, Gu Z, Watabe T, Loda M, Jenkins RB.

Genes Chromosomes Cancer. 2000 Jan;27(1):95-103.

PMID:
10564591
[PubMed - indexed for MEDLINE]
9.

NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines.

Angrand PO, Apiou F, Stewart AF, Dutrillaux B, Losson R, Chambon P.

Genomics. 2001 May 15;74(1):79-88.

PMID:
11374904
[PubMed - indexed for MEDLINE]
10.

Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.

Kittiniyom K, Mastronardi M, Roemer M, Wells WA, Greenberg ER, Titus-Ernstoff L, Newsham IF.

Genes Chromosomes Cancer. 2004 Jul;40(3):190-203.

PMID:
15138999
[PubMed - indexed for MEDLINE]
11.

Loss of heterozygosity at 13q14 correlates with RB1 gene underexpression in human breast cancer.

Bièche I, Lidereau R.

Mol Carcinog. 2000 Nov;29(3):151-8.

PMID:
11108660
[PubMed - indexed for MEDLINE]
12.

bc10: A novel human bladder cancer-associated protein with a conserved genomic structure downregulated in invasive cancer.

Gromova I, Gromov P, Celis JE.

Int J Cancer. 2002 Apr 1;98(4):539-46.

PMID:
11920613
[PubMed - indexed for MEDLINE]
13.

A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice.

Weaver ZA, McCormack SJ, Liyanage M, du Manoir S, Coleman A, Schröck E, Dickson RB, Ried T.

Genes Chromosomes Cancer. 1999 Jul;25(3):251-60.

PMID:
10379871
[PubMed - indexed for MEDLINE]
14.

Identification of CRASH, a gene deregulated in gynecological tumors.

Evtimova V, Zeillinger R, Kaul S, Weidle UH.

Int J Oncol. 2004 Jan;24(1):33-41.

PMID:
14654938
[PubMed - indexed for MEDLINE]
15.

Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma.

Ogushi T, Takahashi S, Takeuchi T, Urano T, Horie-Inoue K, Kumagai J, Kitamura T, Ouchi Y, Muramatsu M, Inoue S.

Cancer Res. 2005 May 1;65(9):3700-6.

PMID:
15867365
[PubMed - indexed for MEDLINE]
Free Article
16.

Identification of a chromosome 18q gene that is altered in colorectal cancers.

Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, et al.

Science. 1990 Jan 5;247(4938):49-56.

PMID:
2294591
[PubMed - indexed for MEDLINE]
17.

Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer.

Sotiropoulou G, Kono M, Anisowicz A, Stenman G, Tsuji S, Sager R.

Mol Med. 2002 Jan;8(1):42-55.

PMID:
11984005
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Human glutamate pyruvate transaminase (GPT): localization to 8q24.3, cDNA and genomic sequences, and polymorphic sites.

Sohocki MM, Sullivan LS, Harrison WR, Sodergren EJ, Elder FF, Weinstock G, Tanase S, Daiger SP.

Genomics. 1997 Mar 1;40(2):247-52.

PMID:
9119391
[PubMed - indexed for MEDLINE]
19.

Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.

Tripathy D, Benz CC.

Cancer Treat Res. 1992;63:15-60. Review.

PMID:
1363356
[PubMed - indexed for MEDLINE]
20.

ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers.

Johnstone CN, Castellví-Bel S, Chang LM, Bessa X, Nakagawa H, Harada H, Sung RK, Piqué JM, Castells A, Rustgi AK.

Gene. 2004 Jul 7;336(1):59-71.

PMID:
15225876
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk